Home  »  Stock   »  Eloxx Pharmaceuticals Inc. (ELOX) is set to bring ...

Eloxx Pharmaceuticals Inc. (ELOX) is set to bring smile on the investors face as Analysts sets mean Target price of $3.00

Eloxx Pharmaceuticals Inc. (ELOX) is priced at $0.15 after the most recent trading session. At the very opening of the session, the stock price was $0.1349 and reached a high price of $0.18, prior to closing the session it reached the value of $0.13. The stock touched a low price of $0.1255.Recently in News on November 10, 2022, Eloxx Pharmaceuticals Reports Third Quarter 2022 Financial and Operating Results and Provides Business Update. Started proof-of-concept Phase 2 clinical trial with ELX-02 in up to eight Alport syndrome patients with nonsense mutations; topline results expected in the first half of 2023. You can read further details here

Eloxx Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.7438 on 01/03/22, with the lowest value was $0.1052 for the same time period, recorded on 11/11/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Eloxx Pharmaceuticals Inc. (ELOX) full year performance was -77.85%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Eloxx Pharmaceuticals Inc. shares are logging -85.63% during the 52-week period from high price, and 37.93% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.11 and $1.01.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2979766 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Eloxx Pharmaceuticals Inc. (ELOX) recorded performance in the market was -79.45%, having the revenues showcasing -68.20% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 12.67M, as it employees total of 28 workers.

The Analysts eye on Eloxx Pharmaceuticals Inc. (ELOX)

During the last month, 2 analysts gave the Eloxx Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.2434, with a change in the price was noted -0.12. In a similar fashion, Eloxx Pharmaceuticals Inc. posted a movement of -45.94% for the period of last 100 days, recording 215,706 in trading volumes.

Technical rundown of Eloxx Pharmaceuticals Inc. (ELOX)

Raw Stochastic average of Eloxx Pharmaceuticals Inc. in the period of last 50 days is set at 27.56%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 53.34%. In the last 20 days, the company’s Stochastic %K was 47.77% and its Stochastic %D was recorded 47.66%.

Considering, the past performance of Eloxx Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -79.45%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -55.56%, alongside a downfall of -77.85% for the period of the last 12 months. The shares increased approximately by 9.92% in the 7-day charts and went up by -1.09% in the period of the last 30 days. Common stock shares were lifted by -68.20% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts